Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 10,813 | 756 | 746 | 580 | 717 |
| Gross Profit | 10,301 | 756 | 746 | 580 | 717 |
| Operating Expenses | 50,982 | 29,834 | 30,579 | 29,661 | 26,577 |
| Operating Income | -40,169 | -29,078 | -29,833 | -29,081 | -25,860 |
| Interest Expense | 782 | 255 | 0 | 0 | 0 |
| Other Income | 1,338 | 700 | 146 | 57 | 32 |
| Pre-tax Income | -39,613 | -28,633 | -29,687 | -29,024 | -25,828 |
| Income Tax | -6,336 | N/A | N/A | -7,056 | N/A |
| Net Income Continuous | -33,277 | -28,633 | -29,687 | -21,968 | -25,828 |
| Net Income | $-33,277 | $-28,633 | $-29,687 | $-21,968 | $-25,828 |
| EPS Basic Total Ops | -0.37 | -0.34 | -0.46 | -0.35 | -0.40 |
| EPS Basic Continuous Ops | -0.37 | -0.34 | -0.46 | -0.35 | -0.41 |
| EPS Diluted Total Ops | -0.37 | -0.34 | -0.46 | -0.35 | -0.40 |
| EPS Diluted Continuous Ops | -0.37 | -0.34 | -0.46 | -0.35 | -0.41 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.34 | -0.46 | -0.35 | -0.41 |
| EBITDA(a) | $-39,706 | $-28,844 | $-29,558 | $-28,788 | $-25,585 |